British Journal of Clinical Pharmacology

Comparison of pharmacokinetics and the exposure–response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus

Pages: 1820-1828

Article date: August 2019

Authors: David Busse, Weifeng Tang, Markus Scheerer, Thomas Danne, Torben Biester, Viktor Sokolov, David Boulton, Joanna Parkinson

Issue highlights

Pages: 1659-1660

Article date: August 2019

Erlotinib treatment induces cytochrome P450 3A activity in non‐small cell lung cancer patients

Pages: 1704-1709

Article date: August 2019

Authors: Anna Svedberg, Svante Vikingsson, Anders Vikström, Niels Hornstra, Magnus Kentson, Eva Branden, Hirsh Koyi, Bengt Bergman, Henrik Gréen

The interaction between rifampicin and lamotrigine: A case report

Pages: 1859-1860

Article date: August 2019

Authors: Jan Wimpelmann, Hans Høvik, Bettina Riedel, Lars Slørdal

Population pharmacokinetic model and Bayesian estimator for 2 tacrolimus formulations in adult liver transplant patients

Pages: 1740-1750

Article date: August 2019

Authors: Camille Riff, Jean Debord, Caroline Monchaud, Pierre Marquet, Jean‐Baptiste Woillard

Exposure‐response modeling of tocilizumab in rheumatoid arthritis using continuous composite measures and their individual components

Pages: 1710-1718

Article date: August 2019

Authors: Carla Bastida, Dolors Soy, Virginia Ruiz‐Esquide, Raimon Sanmartí, Alwin D.R. Huitema

Correction

Pages: 1865-1865

Article date: August 2019

Population pharmacokinetics of immediate‐ and prolonged‐release tacrolimus formulations in liver, kidney and heart transplant recipients

Pages: 1692-1703

Article date: August 2019

Authors: Zheng Lu, Peter Bonate, James Keirns